Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CEREVEL THERAPEUTICS HOLDINGS, INC.
01/10CEREVEL THERAPEUTICS TO PRESENT AT 4 : Additional Details of Phase 2 Program for Emraclidi..
AQ
01/05JPMorgan Starts Cerevel Therapeutics Holdings at Overweight With $50 Price Target
MT
01/03Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021INSIDER SELL : Cerevel Therapeutics Holdings
MT
2021Cerevel Agrees Multi-year Collaboration With Herophilus to Research, Develop Therapeuti..
MT
2021HC Wainwright Starts Cerevel Therapeutics Holdings at Buy With $50 Price Target
MT
2021CVL-231 : Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
PU
2021CEREVEL THERAPEUTICS : Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhum..
PU
2021Cerevel Therapeutics Corporate Presentation
PU
2021Cerevel Therapeutics Reports Third Quarter 2021 Financial Results and Pipeline Updates ..
PU
2021Cerevel Therapeutics to Participate at Upcoming Virtual Investor Conferences
AQ
2021CEREVEL THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Wednesday, Novemb..
AQ
2021CEREVEL THERAPEUTICS : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $37 From..
MT
2021CEREVEL THERAPEUTICS : R&D Day Presentation
PU
2021CEREVEL THERAPEUTICS : Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apath..
GL
2021Cerevel Therapeutics Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apat..
CI
2021CEREVEL THERAPEUTICS : Announces Departure of CFO Kathy Yi (Form 8-K)
PU
2021CEREVEL THERAPEUTICS : CFO Kathy Yi Steps Down; Mark Bodenrader Named Interim CFO
MT
2021CEREVEL THERAPEUTICS : Announces Departure of CFO Kathy Yi
AQ
2021Cerevel Therapeutics Holdings, Inc. Announces Executive Changes
CI
2021CEREVEL THERAPEUTICS : Morgan Stanley Adjusts Cerevel Therapeutics Holdings PT to $39 From..
MT
2021CEREVEL THERAPEUTICS : to Present at Upcoming Virtual Investor Conferences
AQ
2021CEREVEL THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Business Updates ..
PU
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021CEREVEL THERAPEUTICS' : Q2 Loss Narrows, Operating Expenses Grow
MT
2021Cerevel Therapeutics Holdings, Inc. Reports Unaudited Consolidated Earnings Results for..
CI
2021CEREVEL THERAPEUTICS : Announces Redemption of Public Warrants (Form 8-K)
PU
2021CEREVEL THERAPEUTICS : Announces Redemption of Public Warrants
AQ
2021CEREVEL THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Wednesday, Augus..
AQ
2021CEREVEL THERAPEUTICS : Stifel Adjusts Price Target on Cerevel Therapeutics Holdings to $33..
MT
2021CEREVEL THERAPEUTICS : Announces Pricing of $350 Million Public Offering of Common Stock (..
PU
2021CEREVEL THERAPEUTICS : Prices Common Stock Offering at $25 Per Share
MT
2021SECTOR UPDATE : Health Care Stocks Mostly Treading Water Near Wednesday Close
MT
2021CEREVEL THERAPEUTICS : Stock Drops 11% on Public Offering of 14 Million Shares
MT
2021SECTOR UPDATE : Health Care Stocks Slip as Biotechs Rally
MT
2021CEREVEL THERAPEUTICS : to Sell 14 Million Shares in Public Offering
MT
2021SECTOR UPDATE : Health Care Stocks Still Listless Near Session's End
MT
2021SECTOR UPDATE : Health Care Stocks Managing Slight Gains
MT
2021SECTOR UPDATE : Health Care Stocks Flat To Higher Premarket Tuesday
MT
2021Wall Street in Holding Pattern Pre-Bell, Consumer Confidence Data on Tap
MT
2021CEREVEL THERAPEUTICS : Says Phase 1b Clinical Trial of Schizophrenia Drug Candidate CVL-23..
MT
2021CEREVEL THERAPEUTICS : Announces Positive Topline Results for CVL-231 in Phase 1b Clinical..
PU
2021CEREVEL THERAPEUTICS : Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients ..
PU
2021Cerevel Therapeutics Holdings, Inc. Announces Positive Topline Results for Cvl-231 in P..
CI
2021CEREVEL THERAPEUTICS : Morgan Stanley Starts Cerevel Therapeutics Holdings at Overweight W..
MT
2021SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday
MT
2021CEREVEL THERAPEUTICS' : Dementia Therapy Gets US FDA Fast Track Designation
MT
2021Cerevel Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to CVL-87..
CI
2021Cerevel Gets FDA Fast-Track Designation for CVL-871 in Dementia-Related Apathy
DJ
2021CEREVEL THERAPEUTICS : Q1 Net Loss Narrows
MT
2021Cerevel Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings Results f..
CI
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021Cerevel Therapeutics Appoints Scott M. Akamine as Chief Legal Officer, Effective May 24..
CI
2021Cerevel Therapeutics Appoints Abraham N. Ceesay as President, Effective May 3, 2021
CI
2021CEREVEL THERAPEUTICS : Unveils Financing Agreement for Up to $125 Million for Treatment Ta..
MT
2021Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transactio..
CI
2021CEREVEL THERAPEUTICS : Q4 Loss Narrows
MT
2021Cerevel Therapeutics Holdings, Inc. Reports Unaudited Consolidated Financial Results fo..
CI
2021Cerevel Therapeutics Provides Update on Pipeline Progress
CI
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC.( : CERE) added to S&P Global BMI Index
CI
2021CEREVEL THERAPEUTICS HOLDINGS, INC.( : CERE) added to S&P Biotechnology Select Industry In..
CI
2021CEREVEL THERAPEUTICS : to Present at the Cowen 41st Annual Health Care Conference
AQ
2021CEREVEL THERAPEUTICS : Hosts Inaugural Virtual R&D Event to Review Darigabat (CVL-865) and..
AQ
2021Cerevel Therapeutics Holdings, Inc. Announces Board Appointments
CI
2021CEREVEL THERAPEUTICS : Announces the Appointments of Deval Patrick and Deborah Baron to it..
AQ
2020CEREVEL THERAPEUTICS : Jefferies & Co Adjusts Cerevel Therapeutics Holdings PT to $22 From..
MT
2020CEREVEL THERAPEUTICS HOLDINGS, INC.( : CERE) added to S&P TMI Index
CI
2020CEREVEL THERAPEUTICS : Goldman Sachs Starts Cerevel Therapeutics Holdings at Buy With $24 ..
MT
2020CEREVEL THERAPEUTICS : Announces the Appointment of Dr. Ruth McKernan to its Board of Dire..
AQ
2020Cerevel Therapeutics Announces Appointment of Ruth Mckernan to Board of Directors
CI
2020Certain Class B Shares of ARYA Sciences Acquisition Corp II are subject to a Lock-Up Ag..
CI
2020CEREVEL THERAPEUTICS : to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Confer..
AQ
2020CEREVEL THERAPEUTICS : Jefferies & Co Initiates Coverage on Cerevel Therapeutics Holdings ..
MT
1  2Next
Upcoming event on CEREVEL THERAPEUTICS HOLDINGS, INC.
03/23/22